Bilirubin blood test is the process of measuring the amount of bilirubin in a blood, thereby, it is used in the diagnostics of jaundice. High prevalence of neonatal jaundice & increasing per capital income is projected to drive the market growth
Baebies, Inc., a company focused on advancing new-born screening & paediatric testing, eying to gain market share in Bilirubin Blood Test Market by launching their unique Product Finder and announced the first assays on the “FINDER” launch panel, currently under development. The panel includes tests for total serum bilirubin, albumin, direct bilirubin & glucose-6-phosphate dehydrogenase on a single cartridge, making it the first comprehensive, rapid & near-patient testing solution for hyperbilirubinemia. A robust pipeline of future panels for other disorders using the same cartridge on FINDER is also in development. Hyperbilirubinemia is a condition in which bilirubin levels in the blood are elevated and the new-born becomes jaundiced. When unmonitored or untreated, neonatal jaundice can lead to severe neurotoxicity, including kernicterus and other associated morbidities.
Receive a sample report at https://www.marketresearchfuture.com/sample_request/720 .
There is currently a gap in point of care testing devices for G6PD, a deficiency that leads to hyperbilirubinemia and approximately 21% of kernicterus cases. The FINDER launch panel will address a critical need for G6PD testing and brings together the most common analytes used to assess hyperbilirubinemia. Each test on the FINDER launch panel contributes to a more complete understanding of why jaundice develops in a newborn. Rapid access to these measurements may allow clinicians to treat severe neonatal hyperbilirubinemia faster and more effectively, thereby preventing irreversible neurological damage
Neonates have very limited volume of blood available for the many tests and technologies required for current hyperbilirubinemia standard of care. Identifying new-borns at-risk for hyperbilirubinemia using a single drop of blood on FINDER not only reduces the amount of pain a neonate must endure, but also reduces the time to provide physicians with important information that will direct care.
“FINDER” is the only platform specifically designed to address the unique needs of neonatal testing. “FINDER” substantially decreases both sample size and testing time, enables testing in the nursery or anywhere in the hospital, and delivers comprehensive test panels even across multiple test types – to solve acute problems in neonatology. Simple operations and test flexibility enable “FINDER” to provide results in minutes
Bilirubin Blood Test Market – Competitive Analysis
As the market seems to be attractive, growing and profitable, at the same time market has witnessed intense rivalry among existing competitors. Many new entrants expected to enter into bilirubin blood test market. There are many big players in the bilirubin blood test market such as: Koninklijke Philips N.V. (Europe), Beckman Coulter, Inc. (Danaher) (U.S.), Thermo Fisher Scientific Inc. (U.S.), Randox Laboratories Ltd. (Europe), and F. Hoffmann-La Roche AG (Europe)
Browse Complete Report at https://www.marketresearchfuture.com/reports/bilirubin-blood-test-market-720 .
Bilirubin Blood Test Market – Regional Analysis
Asia Pacific is the fastest growing market due to the presence of developing economies like India & China within the region, which has growing healthcare expenditures. Because of favourable government policies is likely to boost the market growth in the presence of a huge opportunity for the untapped market within the region.
North America dominates the bilirubin blood test market due to better & developed healthcare sector & rising healthcare expenditures. Moreover, the high prevalence of neonatal jaundice and developed economies like the U.S. and Canada fuel the market growth within the region. Additionally, the presence of the global players like Beckman Coulter, Inc., and Thermo Fisher Scientific Inc. within the regional boundaries of the North America provides favourable for market growth.
Get a discount at https://www.marketresearchfuture.com/check-discount/720 .
Europe is the second largest bilirubin blood test market, which is followed by Asia Pacific. Availability of funds for research, well-developed healthcare infrastructure, huge patient population, & government support for R&D are likely to drive the market in the Europe.
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –